Literature DB >> 22540896

A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.

Craig Carson1, Bernard Omolo, Haitao Chu, Yingchun Zhou, Maria J Sambade, Eldon C Peters, Patrick Tompkins, Dennis A Simpson, Nancy E Thomas, Cheng Fan, Alain Sarasin, Philippe Dessen, Janiel M Shields, Joseph G Ibrahim, William K Kaufmann.   

Abstract

Melanoma cell lines and normal human melanocytes (NHM) were assayed for p53-dependent G1 checkpoint response to ionizing radiation (IR)-induced DNA damage. Sixty-six percent of melanoma cell lines displayed a defective G1 checkpoint. Checkpoint function was correlated with sensitivity to IR with checkpoint-defective lines being radio-resistant. Microarray analysis identified 316 probes whose expression was correlated with G1 checkpoint function in melanoma lines (P≤0.007) including p53 transactivation targets CDKN1A, DDB2, and RRM2B. The 316 probe list predicted G1 checkpoint function of the melanoma lines with 86% accuracy using a binary analysis and 91% accuracy using a continuous analysis. When applied to microarray data from primary melanomas, the 316 probe list was prognostic of 4-yr distant metastasis-free survival. Thus, p53 function, radio-sensitivity, and metastatic spread may be estimated in melanomas from a signature of gene expression.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540896      PMCID: PMC3397470          DOI: 10.1111/j.1755-148X.2012.01010.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  73 in total

1.  P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.

Authors:  A Poyraz; N Akyürek; I I Gönül; O Erdem
Journal:  J Exp Clin Cancer Res       Date:  2004-12

2.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

3.  Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

Authors:  Mitchell Cheung; Arati Sharma; SubbaRao V Madhunapantula; Gavin P Robertson
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

4.  Development and validation of predictive indices for a continuous outcome using gene expression profiles.

Authors:  Yingdong Zhao; Richard Simon
Journal:  Cancer Inform       Date:  2010-05-07

5.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

6.  The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.

Authors:  Hong Yu; Ronan McDaid; John Lee; Patricia Possik; Ling Li; Suresh M Kumar; David E Elder; Patricia Van Belle; Phyllis Gimotty; Matt Guerra; Rachel Hammond; Katharine L Nathanson; Maria Dalla Palma; Meenhard Herlyn; Xiaowei Xu
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

7.  Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.

Authors:  William K Kaufmann; Kathleen R Nevis; Pingping Qu; Joseph G Ibrahim; Tong Zhou; Yingchun Zhou; Dennis A Simpson; Jennifer Helms-Deaton; Marila Cordeiro-Stone; Dominic T Moore; Nancy E Thomas; Honglin Hao; Zhi Liu; Janiel M Shields; Glynis A Scott; Norman E Sharpless
Journal:  J Invest Dermatol       Date:  2007-06-28       Impact factor: 8.551

8.  Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Authors:  Soledad R Alonso; Pablo Ortiz; Marina Pollán; Beatriz Pérez-Gómez; Lydia Sánchez; Ma Jesús Acuña; Raquel Pajares; Francisco J Martínez-Tello; Carlos M Hortelano; Miguel A Piris; José L Rodríguez-Peralto
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

9.  Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi.

Authors:  Debdutta Bandyopadhyay; Jonathan L Curry; Qiushi Lin; Hunter W Richards; Dahu Chen; Peter J Hornsby; Nikolai A Timchenko; Estela E Medrano
Journal:  Aging Cell       Date:  2007-06-18       Impact factor: 9.304

10.  An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.

Authors:  Andrea H Bild; Joel S Parker; Adam M Gustafson; Chaitanya R Acharya; Katherine A Hoadley; Carey Anders; P Kelly Marcom; Lisa A Carey; Anil Potti; Joseph R Nevins; Charles M Perou
Journal:  Breast Cancer Res       Date:  2009-07-28       Impact factor: 6.466

View more
  16 in total

1.  Is activation of the intra-S checkpoint in human fibroblasts an important factor in protection against UV-induced mutagenesis?

Authors:  Christopher D Sproul; Shangbang Rao; Joseph G Ibrahim; William K Kaufmann; Marila Cordeiro-Stone
Journal:  Cell Cycle       Date:  2013-09-25       Impact factor: 4.534

2.  IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

Authors:  Craig C Carson; Stergios J Moschos; Sharon N Edmiston; David B Darr; Nana Nikolaishvili-Feinberg; Pamela A Groben; Xin Zhou; Pei Fen Kuan; Shaily Pandey; Keefe T Chan; Jamie L Jordan; Honglin Hao; Jill S Frank; Dennis A Hopkinson; David C Gibbs; Virginia D Alldredge; Eloise Parrish; Sara C Hanna; Paula Berkowitz; David S Rubenstein; C Ryan Miller; James E Bear; David W Ollila; Norman E Sharpless; Kathleen Conway; Nancy E Thomas
Journal:  Clin Cancer Res       Date:  2015-05-01       Impact factor: 12.531

3.  ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.

Authors:  Chi-Fen Chen; Rolando Ruiz-Vega; Priya Vasudeva; Francisco Espitia; Tatiana B Krasieva; Sebastien de Feraudy; Bruce J Tromberg; Sharon Huang; Chad P Garner; Jie Wu; Dave S Hoon; Anand K Ganesan
Journal:  Cell Rep       Date:  2017-03-07       Impact factor: 9.423

4.  Effective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines.

Authors:  Marila Cordeiro-Stone; John J McNulty; Christopher D Sproul; Paul D Chastain; Eugene Gibbs-Flournoy; Yingchun Zhou; Craig Carson; Shangbang Rao; David L Mitchell; Dennis A Simpson; Nancy E Thomas; Joseph G Ibrahim; William K Kaufmann
Journal:  Pigment Cell Melanoma Res       Date:  2015-11-03       Impact factor: 4.693

5.  Mechanisms of chromosomal instability in melanoma.

Authors:  William K Kaufmann; Craig C Carson; Bernard Omolo; Adam J Filgo; Maria J Sambade; Dennis A Simpson; Janiel M Shields; Joseph G Ibrahim; Nancy E Thomas
Journal:  Environ Mol Mutagen       Date:  2014-02-24       Impact factor: 3.216

Review 6.  Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Authors:  Aiman Q Khan; Jeffrey B Travers; Michael G Kemp
Journal:  Environ Mol Mutagen       Date:  2018-02-21       Impact factor: 3.216

7.  MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

Authors:  Jennifer Schlegel; Maria J Sambade; Susan Sather; Stergios J Moschos; Aik-Choon Tan; Amanda Winges; Deborah DeRyckere; Craig C Carson; Dimitri G Trembath; John J Tentler; S Gail Eckhardt; Pei-Fen Kuan; Ronald L Hamilton; Lyn M Duncan; C Ryan Miller; Nana Nikolaishvili-Feinberg; Bentley R Midkiff; Jing Liu; Weihe Zhang; Chao Yang; Xiaodong Wang; Stephen V Frye; H Shelton Earp; Janiel M Shields; Douglas K Graham
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

8.  A prognostic signature of G(2) checkpoint function in melanoma cell lines.

Authors:  Bernard Omolo; Craig Carson; Haitao Chu; Yingchun Zhou; Dennis A Simpson; Jill E Hesse; Richard S Paules; Kristine C Nyhan; Joseph G Ibrahim; William K Kaufmann
Journal:  Cell Cycle       Date:  2013-03-01       Impact factor: 4.534

9.  Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.

Authors:  William R Jeck; Joel Parker; Craig C Carson; Janiel M Shields; Maria J Sambade; Eldon C Peters; Christin E Burd; Nancy E Thomas; Derek Y Chiang; Wenjin Liu; David A Eberhard; David Ollila; Juneko Grilley-Olson; Stergios Moschos; D Neil Hayes; Norman E Sharpless
Journal:  Pigment Cell Melanoma Res       Date:  2014-04-07       Impact factor: 4.693

10.  Gene expression signatures but not cell cycle checkpoint functions distinguish AT carriers from normal individuals.

Authors:  Liwen Zhang; Dennis A Simpson; Cynthia L Innes; Jeff Chou; Pierre R Bushel; Richard S Paules; William K Kaufmann; Tong Zhou
Journal:  Physiol Genomics       Date:  2013-08-13       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.